Outcomes Of The TOURMALINE-MM3 Study
Peter Vorhees, MD, Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute, discusses Outcomes Of The TOURMALINE-MM3 Study. At The...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy And The Treatment Of Hematologic Malignancies
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical Center, discusses Immunotherapy And The Treatment Of Hematologic Ma...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
The Impact Of The New Induction Regimen In PTCL
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, discusses The Impact Of The New Induction Regimen In...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Anti-BCMA CAR-T Cell Therapy For MM Patients
David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses Anti-BCMA CAR-T Cell Therapy For MM Patients. At The 60th ASH Annual Meeting on D...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Management Of Common Toxicities With CAR-T Therapies
Julie Vose, MD Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Management Of Common Toxicities With CAR-T Therapies. At The 60th ASH Ann...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Effectiveness Of Anti-BCMA CAR-T Cell Therapy
Rafael Fonseca, MD Hematologist, Mayo Clinic, discusses Effectiveness Of Anti-BCMA CAR-T Cell Therapy. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Outcomes Of The POLLUX And CASTOR Studies
Rafael Fonseca, MD Hematologist, Mayo Clinic, discusses Outcomes Of The POLLUX And CASTOR Studies. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Outcomes Of CA204-142 In MM
Sundar Jagannath, MD Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, discusses Outcomes Of CA204-142 In MM. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Reliability Of The FLT3 Mutation Test
John Burke, MD Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Reliability Of The FLT3 Mutation Test. At The 60th A...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Outcomes From The iLLUMINATE Trial
Carol Moreno, MD, PhD Hematologist, University of Barcelona, discusses Outcomes From The iLLUMINATE Trial. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
What Regimens Are Being Used For MM Patients Today
Peter Vorhees, MD Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute, discusses What Regimens Are Being Used For MM Patients ...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Study Examining The Use Of CAR-T Therapy In ALL
Samer Khaled, MD Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses Study Examining The Use Of CAR-T Therapy In ALL. At The 60th ASH A...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Novel Treatment Research Regarding Transplants At City Of Hope
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, discusses Novel Treatment Research Regarding Transpl...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
How City Of Hope Has Overcome Logistical Hurdles Associated With CAR-T
Elizabeth Budde, MD Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses How City Of Hope Has Overcome Logistical Hurdles Associated With C...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
The CLL-14 Studies Importance In Determining CLL Treatment Strategies
Jeff Sharman, MD Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses The CLL-14 Studies Importance In Determining CLL ...
Author: obr
Added: 01/14/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 14, 2019 Category: Cancer & Oncology Source Type: podcasts
